NEWTOWN, Pa.--(BUSINESS WIRE)--BioClinica™, Inc., (NASDAQ: BIOC), a global provider of clinical trial management services, is the first clinical technology provider to offer a reporting solution that incorporates the industry-standard performance metrics for clinical trials as defined by the Metrics Champion Consortium (MCC).
